Clinical Research

Regulator Agrees Minimum Ages for UK Puberty‑Blocker Trial but Recruitment Remains Paused

The MHRA and King's College London approved a revised Pathways protocol that adds age limits and safeguards, yet legal challenges and parliamentary moves leave recruitment on hold.